Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

19 Jan 2010 07:00

RNS Number : 7493F
BrainJuicer Group PLC
19 January 2010
Ā 



Press releaseĀ 

19Ā JanuaryĀ 2010

BrainJuicer Group PLC

("BrainJuicer" orĀ "theĀ Group"Ā or "the Company")

TradingĀ Update

Profitable growth

Leading international online market researcher, BrainJuicer Group PLC, today gives the following update on trading ahead of its Preliminary ResultsĀ for the financial year ended 31 December 2009Ā which will be announced onĀ 9Ā March 2010.

Highlights:

Ā 

Ā·; Ā 
Results expected to be in line with market expectations; profitable growth continues despite difficult market conditions and significant investment in product development, operations and technology
Ā·;
Revenue up around 26% to approximately £11.7 million (2008: £9.3 million)
Ā·;
Operating profit up by more than 25% to over £1.6 million (2008: £1.29 million)
Ā·;
Strong financial position with cash up to around £2.3 million at 31 December 2009 (30 June 2009: £1.2m) and no debt
Ā·;
Innovative ā€˜Juicy’ products grew 65% to over 60% of turnover [2008: 46%]
Ā·;
Working with 11 of the world’s top 20 buyers of market research [9 in 2008]
Ā·;
Both new offices, Switzerland and Germany achieved profitability in their first 18 months

BrainJuicer's reputationĀ for innovationĀ grewĀ furtherĀ in 2009Ā with revenue from the Group's strategically important 'Juicy' productsĀ making significant gainsĀ and now accounting for over 60% ofĀ the Group'sĀ revenue (2008: 46%).Ā These products are being sold to some of the world's largest buyers of market research. In 2009Ā the Company'sĀ clients included 11 of the world's top 20 buyers of market research, up from 9 in 2008, and revenue from these clients grew byĀ over 70%. Client satisfaction remains high with repeat business at around 80%.

RevenueĀ increaseĀ wasĀ driven by continued strong progress in theĀ US,Ā growing at aroundĀ 60%,Ā and byĀ veryĀ encouraging contributions fromĀ the new offices inĀ SwitzerlandĀ andĀ Germany. The Company'sĀ  UKĀ business recovered after a slow start toĀ theĀ yearĀ (revenue for the full year wasĀ aroundĀ 2%Ā lower), andĀ Dutch revenue grewĀ aboutĀ 10%. Overall the Group achievedĀ approximatelyĀ 26% revenue growthĀ (21% on aĀ constantĀ currency basis).

Operating profitĀ isĀ upĀ by more thanĀ 25%Ā whilst having at the sameĀ timeĀ invested more than ever before inĀ developing and validatingĀ products,Ā inĀ back-office operations andĀ inĀ the Company'sĀ softwareĀ  platform. We believeĀ this investmentĀ will drive future growth.

The GroupĀ has reached an agreement to acquire High Level Research Inc., its Canadian licencee, for a nominal sum.Ā Ā This will be managed as a regional office within our North American business.

John Kearon,Ā CEOĀ of BrainJuicer, commented: "To have grown so strongly in a year whenĀ spending onĀ market researchĀ seems to haveĀ declined for the first time in 25 years is a tremendous achievement and testament to the attraction of our innovative 'Juicy' products, expanded geographic footprint and talented researchers to our major multinational client base. Despite the dire economic conditions, we have continued to make significant investments.Ā Ā WhilstĀ manyĀ of the largest research agenciesĀ have apparentlyĀ declined and retrenched during 2009, we continued to invest heavily inĀ new and existing 'Juicy' products, enhancingĀ the efficiency and scalability ofĀ our technology platformĀ andĀ expanding our geographic footprint. These investmentsĀ will, we believe, enable us to secure the global and regional mandates which we need to fulfil our longer term ambitions.

"The Board isĀ confident that in 2010 we can continue to grow our businessĀ throughĀ  furtherĀ productĀ  innovationĀ andĀ increasing our market share withĀ major multinationalĀ customers."

An analyst presentation, given by John Kearon,Ā CEO, and James Geddes, CFO, will be held at 9.30am onĀ 9Ā March 2010 at Abchurch's office, 16thĀ Floor,Ā 125 Old Broad Street,Ā London,Ā EC2N 1AR.

- Ends -

For further information, please contact:

BrainJuicer GroupĀ PLC

Tel: +44 (0)Ā 20 7043 1000

John Kearon, Chief Executive Officer

john.kearon@brainjuicer.com

James Geddes, Chief Financial Officer

james.geddes@brainjuicer.com

Canaccord Adams

Tel: +44 (0)Ā 20 7050 6500

Mark Williams /Ā Henry Fitzgerald-O'Connor

www.canaccordadams.com

Media enquiries:

Abchurch Communications

Heather Salmond /Ā Joanne Shears

Tel: +44 (0)Ā 20 7398 7709

joanne.shears@abchurch-group.com

www.abchurch-group.com

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
TSTUWOWRROAAAAR
Date   Source Headline
18th Aug 20177:00 amRNSTrading Update
11th Jul 20171:18 pmRNSAnnual Report and Notice of AGM
3rd Jul 20177:59 amRNSTotal Voting Rights
26th Jun 201711:23 amRNSDirector/PDMR Shareholding
16th Jun 20171:33 pmRNSExercise of Options and Director Dealing
15th Jun 20177:00 amRNSDividend Declaration
15th Jun 20177:00 amRNSDirectorate Change
15th Jun 20177:00 amRNSFinancial results to 31 March 2017
11th May 20175:47 pmRNSHolding(s) in Company
19th Apr 20177:00 amRNSTrading Update
3rd Apr 20177:00 amRNSChange of Name
24th Mar 20177:00 amRNSChange of Name
22nd Mar 20174:31 pmRNSGrant of Options
22nd Mar 20173:44 pmRNSResult of General Meeting
1st Mar 20172:02 pmRNSTotal Voting Rights
28th Feb 20172:58 pmRNSDirector/PDMR Shareholding
24th Feb 20177:00 amRNSNotice of GM
10th Feb 20173:46 pmRNSExercise of Options
9th Feb 20177:00 amRNSResults for the 12 months ended 31 December 2016
7th Feb 20177:00 amRNSBoard Appointment
20th Jan 20177:00 amRNSTrading Update
9th Dec 20167:00 amRNSTrading Update
1st Dec 201612:45 pmRNSTotal Voting Rights
1st Nov 20165:34 pmRNSTransaction in Own Shares
1st Nov 20161:35 pmRNSTotal Voting Rights
13th Oct 20165:34 pmRNSTransaction in Own Shares
12th Oct 20161:44 pmRNSTransaction in Own Shares
4th Oct 20167:00 amRNSDirectorPDMR Dealing and Transaction in Own Shares
30th Sep 20165:15 pmRNSTransaction in Own Shares
27th Sep 20164:57 pmRNSExercise of Options, PDMR Shareholding
22nd Sep 20167:00 amRNSExercise of Options and Transaction in Own Shares
22nd Sep 20167:00 amRNSTransaction in Own Shares
20th Sep 20166:23 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSTransaction in Own Shares
16th Sep 20167:00 amRNSInterim Results
16th Sep 20167:00 amRNSDividends and Share Buyback
9th Sep 20164:39 pmRNSHolding(s) in Company
9th Sep 20161:20 pmRNSHolding(s) in Company
26th Aug 201611:42 amRNSHolding(s) in Company
16th Aug 20164:15 pmRNSAdditional Listing
15th Jul 20167:00 amRNSTrading Update
20th Jun 20164:40 pmRNSTransaction in Own Shares
6th Jun 20164:45 pmRNSDirector Dealing
6th Jun 201611:17 amRNSDirector Dealing
3rd Jun 20162:17 pmRNSHolding(s) in Company
2nd Jun 20166:02 pmRNSDirector Dealing and Transaction in Own Shares
18th May 20165:46 pmRNSDirector Dealing and Transaction in Own Shares
6th May 201612:19 pmRNSResult of AGM
4th May 20163:55 pmRNSTransaction in Own Shares
22nd Apr 20163:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.